Bill Detail
An act to amend the Controlled Drugs and Substances Act and the Food and Drugs Act
This enactment amends the Controlled Drugs and Substances Act and the Food and Drugs Act to allow psilocin and psilocybin to be used for medical treatment in accordance with the Narcotic Control Regulations. It also provides for the automatic approval of requests for priority review for certain new drugs.
This bill, titled the 'Controlled Drugs and Substances Act and the Food and Drugs Act Amendment Act', aims to change how psilocybin and psilocin are treated in Canada. Specifically, it would allow these substances to be used for medical treatments under certain regulations. This could make it easier for patients to access therapies involving these compounds if prescribed by healthcare professionals. The bill also proposes to automatically approve priority review requests for certain new drugs, speeding up their market entry.